Acquista Criptovalute
Paga con
USD
USD
Buy & Sell
Hot
Supports Visa, Mastercard, SEPA & more
P2P
0 Fees
Flexible trading, zero fees
Gate Card
Use your crypto for payments worldwide
Mercati
Trading
Basic
Advanced
Futures
Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Opzioni
Hot
Trade European-style Vanilla Options
Conto unificato
Massimizza l'efficienza del tuo capitale
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Guadagna
Lancia
CandyDrop
Raccogli le caramelle per guadagnare airdrop
Launchpool
Staking rapido, guadagna potenziali nuovi token
HODLer Airdrop
Fai holding GT e ottieni enormi airdrop gratuitamente
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Investimento
Square
Square
Post, share, and explore crypto trends
Live
moments live
Live crypto market analysis
Chat
Chat with crypto traders
News
What is happening in crypto
flower_head
Altro
Promozioni
AI
Altro
TradFi
WCTC S8
Rewards
TFC

Prezzo Truist Financial Corp

Closed
TFC
$50,93
-$0,57(-1,10%)

*Data last updated: 2026-05-04 02:26 (UTC+8)

As of 2026-05-04 02:26, Truist Financial Corp (TFC) is priced at $50,93, with a total market cap of $63,45B, a P/E ratio of 11,75, and a dividend yield of 4,08%. Today, the stock price fluctuated between $50,75 and $51,37. The current price is 0,35% above the day's low and 0,85% below the day's high, with a trading volume of 4,84M. Over the past 52 weeks, TFC has traded between $44,27 to $52,12, and the current price is -2,28% away from the 52-week high.

TFC Key Stats

Yesterday's Close$51,50
Market Cap$63,45B
Volume4,84M
P/E Ratio11,75
Dividend Yield (TTM)4,08%
Dividend Amount$0,52
Diluted EPS (TTM)4,42
Net Income (FY)$5,30B
Revenue (FY)$30,43B
Earnings Date2027-01-20
EPS Estimate1,25
Revenue Estimate$5,45B
Shares Outstanding1,23B
Beta (1Y)0.869
Ex-Dividend Date2026-05-08
Dividend Payment Date2026-06-01

About TFC

Truist Financial Corporation, a holding company, provides banking and trust services in the Southeastern and Mid-Atlantic United States. The company operates through three segments: Consumer Banking and Wealth, Corporate and Commercial Banking, and Insurance Holdings. Its deposit products include noninterest-bearing checking, interest-bearing checking, savings, and money market deposit accounts, as well as certificates of deposit and individual retirement accounts. The company also provides funding; asset management; automobile lending; bankcard lending; consumer finance; home equity and mortgage lending; insurance, such as property and casualty, life, health, employee benefits, workers compensation and professional liability, surety coverage, title, and other insurance products; investment brokerage; mobile/online banking; and payment, lease financing, small business lending, and wealth management/private banking services. In addition, it offers association, capital market, institutional trust, insurance premium and commercial finance, international banking, leasing, merchant, commercial deposit and treasury, government finance, commercial middle market lending, small business and student lending, floor plan and commercial mortgage lending, mortgage warehouse lending, private equity investment, real estate lending, and supply chain financing services. Further, the company provides corporate and investment banking, retail and wholesale brokerage, securities underwriting, and investment advisory services. As of December 31, 2021, the company operated through 2,517 banking offices. The company was formerly known as BB&T Corporation and changed its name to Truist Financial Corporation in December 2019. Truist Financial Corporation was founded in 1872 and is headquartered in Charlotte, North Carolina.
SectorFinancial Services
IndustryBanks - Regional
CEOWilliam Henry Rogers Jr.
HeadquartersCharlotte,NC,US
Official Websitehttps://www.truist.com

Truist Financial Corp (TFC) FAQ

What's the stock price of Truist Financial Corp (TFC) today?

x
Truist Financial Corp (TFC) is currently trading at $50,93, with a 24h change of -1,10%. The 52-week trading range is $44,27–$52,12.

What are the 52-week high and low prices for Truist Financial Corp (TFC)?

x

What is the price-to-earnings (P/E) ratio of Truist Financial Corp (TFC)? What does it indicate?

x

What is the market cap of Truist Financial Corp (TFC)?

x

What is the most recent quarterly earnings per share (EPS) for Truist Financial Corp (TFC)?

x

Should you buy or sell Truist Financial Corp (TFC) now?

x

What factors can affect the stock price of Truist Financial Corp (TFC)?

x

How to buy Truist Financial Corp (TFC) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Other Trading Markets

TFC
CFD
Fai trading

Hot Posts su Truist Financial Corp (TFC)

SelfRugger

SelfRugger

3 ore fa
High Growth Tech Stocks with Promising Global Potential ======================================================= Simply Wall St Thu, February 19, 2026 at 6:38 PM GMT+9 4 min read In this article: 002558.SZ -0.78% 300502 BSLN 300308 300394.SZ -5.58% Amidst a backdrop of declining U.S. stock indexes and heightened concerns over AI's disruptive potential, the global market landscape remains dynamic, with significant employment gains in the U.S. affecting rate cut expectations and European markets experiencing volatility due to similar AI apprehensions. In this environment, identifying high growth tech stocks with promising global potential requires an understanding of how these companies can navigate current challenges such as technological disruption and economic shifts while capitalizing on innovation to drive future growth. ### Top 10 High Growth Tech Companies Globally | Name | Revenue Growth | Earnings Growth | Growth Rating | | --- | --- | --- | --- | | Giant Network Group | 36.46% | 42.98% | ★★★★★★ | | Shengyi TechnologyLtd | 24.78% | 35.24% | ★★★★★★ | | Shengyi Electronics | 30.66% | 38.51% | ★★★★★★ | | Suzhou TFC Optical Communication | 41.57% | 37.38% | ★★★★★★ | | eWeLLLtd | 20.32% | 22.54% | ★★★★★★ | | Gold Circuit Electronics | 33.23% | 39.06% | ★★★★★★ | | CD Projekt | 32.71% | 43.20% | ★★★★★★ | | Suzhou Dongshan Precision Manufacturing | 31.28% | 73.82% | ★★★★★★ | | Co-Tech Development | 35.68% | 75.80% | ★★★★★★ | | CARsgen Therapeutics Holdings | 100.40% | 118.16% | ★★★★★★ | Click here to see the full list of 212 stocks from our Global High Growth Tech and AI Stocks screener. Let's dive into some prime choices out of from the screener. Basilea Pharmaceutica --------------------- **Simply Wall St Growth Rating:** ★★★★☆☆ **Overview:** Basilea Pharmaceutica AG is a Swiss commercial-stage biotech company specializing in the development and commercialization of treatments for severe bacterial and fungal infections, with a market cap of CHF663.56 million. **Operations:** Basilea Pharmaceutica focuses on developing and commercializing therapies for severe bacterial and fungal infections. The company's revenue model is centered around its proprietary pharmaceuticals, with a significant portion of its income derived from licensing agreements and partnerships. Basilea Pharmaceutica, amid a challenging landscape marked by a 48.2% decline in earnings last year, still projects robust future growth with expected annual earnings increases of 40.6%. This optimism is underscored by recent strategic alliances aimed at addressing significant unmet medical needs through novel antifungal and antibiotic therapies. Notably, their collaboration with Prokaryotics to develop broad-spectrum antifungals targets critical pathogens identified by the WHO, potentially reshaping treatment paradigms in infectious diseases. Moreover, Basilea's partnership with INCATE expands its influence in antimicrobial innovation, enhancing its portfolio and reinforcing its commitment to tackling global health challenges through cutting-edge research and development efforts. Story Continues * Click here to discover the nuances of Basilea Pharmaceutica with our detailed analytical health report. * Evaluate Basilea Pharmaceutica's historical performance by accessing our past performance report. SWX:BSLN Revenue and Expenses Breakdown as at Feb 2026 Zhongji Innolight ----------------- **Simply Wall St Growth Rating:** ★★★★★★ **Overview:** Zhongji Innolight Co., Ltd. specializes in the design, R&D, production, and sales of optical communication transceiver modules and optical devices in China, with a market cap of CN¥590 billion. **Operations:** The company focuses on optical communication transceiver modules and devices, generating revenue primarily through their design, production, and sales. It operates within the Chinese market and holds a significant position in the optical communications industry. Zhongji Innolight's recent shareholder meetings indicate strategic moves, possibly aligning with its robust earnings growth of 84.7% over the past year, outpacing the Communications industry's 12.5%. With revenue and earnings forecasted to grow at annual rates of 38.7% and 40.8% respectively, significantly above the CN market averages of 14.9% and 28.2%, the company is poised for substantial expansion. This growth trajectory is complemented by a strong return on equity projection at 40.3%, suggesting efficient management and promising future prospects in high-tech sectors. * Unlock comprehensive insights into our analysis of Zhongji Innolight stock in this health report. * Assess Zhongji Innolight's past performance with our detailed historical performance reports. SZSE:300308 Revenue and Expenses Breakdown as at Feb 2026 Eoptolink Technology -------------------- **Simply Wall St Growth Rating:** ★★★★★★ **Overview:** Eoptolink Technology Inc., Ltd. specializes in the research, development, production, and sale of optical modules for optical communication applications both domestically and internationally, with a market cap of CN¥363.92 billion. **Operations:** Eoptolink Technology Inc., Ltd. focuses on the optical communication sector, generating revenue primarily from its optical communication equipment segment, which amounted to CN¥20.02 billion. Eoptolink Technology has demonstrated a remarkable trajectory with its earnings surging by 294.7% over the past year, significantly outstripping the Electronic industry's growth of 10.6%. This growth is supported by robust revenue projections expected to climb at an annual rate of 44%, far surpassing the CN market average of 14.8%. The company's commitment to innovation is evident in its R&D spending, which has been strategically aligned with emerging tech trends, ensuring it remains at the forefront of technological advancements and market demands. * Take a closer look at Eoptolink Technology's potential here in our health report. * Learn about Eoptolink Technology's historical performance. SZSE:300502 Earnings and Revenue Growth as at Feb 2026 Next Steps ---------- * Navigate through the entire inventory of 212 Global High Growth Tech and AI Stocks here. * Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. * Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide. Contemplating Other Strategies? ------------------------------- * Explore high-performing small cap companies that haven't yet garnered significant analyst attention. * Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. * Find companies with promising cash flow potential yet trading below their fair value. _ This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ _Companies discussed in this article include SWX:BSLN SZSE:300308 and SZSE:300502._ **Have feedback on this article? Concerned about the content? Get in touch with us directly.**_ Alternatively, email [email protected]_ Terms and Privacy Policy Privacy Dashboard More Info
0
0
0
0
NodeGuardian

NodeGuardian

13 ore fa
Concord Asset Management LLC VA significantly increased its stake in Truist Financial Corporation, purchasing an additional 55,237 shares to bring its total holdings to 65,686 shares valued at $3.23 million. Truist Financial reported strong quarterly earnings, beating expectations with $1.09 EPS and $5.20 billion in revenue, and maintains a "Moderate Buy" consensus rating from analysts with a target price of $55.41. The company also declared a quarterly dividend of $0.52 per share, offering an annualized yield of 4.1%.
0
0
0
0
NodeGuardian

NodeGuardian

23 ore fa
Concurrent Investment Advisors LLC increased its stake in Truist Financial Corporation (NYSE:TFC) by 70.9%, purchasing an additional 111,518 shares to hold a total of 268,702 shares valued at $13.22 million. Other institutional investors like Wellington Management Group and Jennison Associates also significantly boosted their holdings. However, insiders including CFO Michael Baron Maguire and CAO Cynthia B. Powell have sold shares, reducing their ownership in the company.
0
0
0
0